Kenneth Hershon MD
Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Pituitary Disorders & Neuroendocrinology
Physician
Join to View Full Profile
3003 New Hyde Park RdSte 201New Hyde Park, NY 11042
Phone+1 516-327-0850
Fax+1 516-327-0920
Dr. Hershon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1981
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1976 - 1979
Albert Einstein College of MedicineClass of 1976
Certifications & Licensure
NY State Medical License 1977 - 2025
WA State Medical License 1979 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Start of enrollment: 2012 Jan 01
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
- Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension Start of enrollment: 2023 Nov 22
Roles: Contact
Publications & Presentations
PubMed
- 18 citationsImportance of Postprandial Glucose in Relation to A1C and Cardiovascular DiseaseKenneth S. Hershon, Barbara R. Hirsch, Ola Odugbesan
Clinical Diabetes. 2019-07-01 - 12 citationsOptions for empagliflozin in combination therapy in type 2 diabetes mellitus.Kenneth S Hershon
International Journal of General Medicine. 2016-05-25 - 13 citationsMechanistic and clinical aspects of renin-angiotensin-aldosterone system blockade in the prevention of diabetes mellitus and cardiovascular disease.Kenneth S. Hershon
Endocrine Practice. 2011-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
